Alexion Pharmaceuticals, Inc. News
Novartis and Roche Have Expensive Drugs That Scare Away Competitors
A brief snapshot of some medical breakthroughs that are among the costliest in the world.
Moderna Gets European Nod for Adolescent COVID-19 Vaccine
European regulators 'adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine,' Moderna says.
Five Top Stock Gainers for Friday: Moderna, MoneyGram, GX Acquisition
Moderna, MoneyGram, GX Acquisition, Byrna Technologies and Zynex are five top stock gainers for Friday.
Premarket Movers Friday: Moderna, Didi, MoneyGram
Stocks moving in premarket trading Friday include Moderna, Didi Global, MoneyGram, Intel and GameStop.
Moderna Surges to Record High as Vaccine Maker Added to S&P 500
Moderna will replace Alexion Pharmaceuticals in the S&P 500 benchmark following that group's $39 billion takeover by Britain's AstraZeneca in December of last year.
Dow Futures Higher After Retail Sales Surprise; Moderna Tabbed For S&P 500 Inclusion
The Dow is on pace for its fourth weekly gain as investors continue to favor stocks in the face of increasing uncertainty over growth and inflation.
Intel, Moderna, F45 Training, Kansas City Southern - 5 Things You Must Know Friday
Stock futures rise modestly Friday; Intel reportedly is exploring an acquisition of GlobalFoundries; Moderna will join the S&P 500 index; F45 makes muted stock market debut.
5 Top Stock Gainers for Thursday: Verb Technology, Delta, Nikola
Verb Technology, Delta Air Lines, Nikola, Honeywell Industries and U.S. Bancorp are five top stock gainers for Thursday.
AstraZeneca Drug Reduces Relapse, Death in Breast Cancer Patients
AstraZeneca's treatment reduced the combined risk of recurrence of cancer or death from any cause by 42%.
Apellis Jumps on Blood Disease Treatment Approval
Apellis says the U.S. Food & Drug Administration has approved its Empaveli treatment for a rare blood disease.
Breaking News
Bed, Bath & Beyond Stock Plummets As Ryan Cohen Nets $60 Million From Activist Exit
GameStop chairman Ryan Cohen completed his exit from an activist stake in Bed, Bath & Beyond Thursday after riding a meme-lead rally to a near $60 million in profits.
Home Depot Stock Gains On $15 Billion Buyback, $1.90 Dividend; Ted Decker Named Chairman
Home Depot closed out a busy week by naming CEO Ted Decker as chairman, unveiling a new $15 billion buyback and declaring a $1.90 per share dividend.
Applied Materials Stock Lower After Q3 Earnings, Chip Market Caution
"Although we're confident in our ability to perform well in a range of market scenarios, we're mindful of the current macroeconomic trends," said CEO Gary Dickerson.
Deere Stock Tumbles As Supply Chain Pressures Bring Q3 Earnings Miss, Profit Forecast Cut
Deere's third quarter profits "reflected higher costs and production inefficiencies driven by the difficult supply-chain situation," said CEO John May.